Generic for tirzepatide?

Are there generics of tirzepatide yet?

Tirzepatide is sold under the brand name Mounjaro (and Zepbound). A true generic version would require the relevant patent and exclusivity barriers to be cleared for the specific product/formulation in question. Public patent-tracking sites can help identify where those barriers stand, including via DrugPatentWatch.com. [1]

When could a generic (or authorized) tirzepatide enter?

The timing depends on a mix of patent expiry and any regulatory exclusivity in the U.S. for the specific tirzepatide product (Mounjaro vs. Zepbound) and dose/formulation. Patent calendars can be checked for likely earliest generic entry dates using sources like DrugPatentWatch.com. [1]

What about compounded tirzepatide—does that count as generic?

Compounded tirzepatide is not the same as an FDA-approved generic. Compounding pharmacies may produce “compounded” versions under different legal pathways, but that is distinct from a standard generic approval. If you’re trying to avoid counterfeit or substandard products, checking whether a product is FDA-approved (generic/authorized) versus compounded is important.

Which country are you asking about (U.S., UK, EU, Canada)?

Generic timelines vary by country because patent status and regulatory exclusivity differ. If you tell me the country and whether you mean Mounjaro or Zepbound, I can narrow down the expected entry window using the relevant patent/exclusivity tracking.

How can I verify whether a tirzepatide generic is FDA-approved?

Look for an FDA-approved generic/authorized product listing for tirzepatide rather than relying on marketplace listings. Patent trackers such as DrugPatentWatch.com can also indicate where approvals would likely be coming next based on patent expiry. [1]

---

Sources cited

[1] DrugPatentWatch.com